Vasopressor requirement during targeted temperature management for out-of-hospital cardiac arrest caused by acute myocardial infarction without cardiogenic shock

다국어 초록 (Multilingual Abstract)

Objective We investigated whether patients with out-of-hospital cardiac arrest (OHCA) due to an acute myocardial infarction without cardiogenic shock required higher doses of vasopressors with low targeted temperature management (TTM) after return of spontaneous circulation.
Methods We included consecutive comatose patients resuscitated from OHCA between January 2011 and December 2013. Patients with return of spontaneous circulation, regional wall motion abnormality on echocardiography, and coronary artery stenosis of ≥70% on percutaneous coronary artery angiography were enrolled. These patients received 36°C TTM or 33°C TTM following approval of TTM by patients’ next-of-kin (36°C and 33°C TTM groups, respectively). The cumulative vasopressor index was compared between groups.
Results During induction phase, dose of vasopressors did not differ between groups. In the maintenance phase, the norepinephrine dose was 0.37±0.57 and 0.26±0.91 μg·kg-1·min-1 in the 33°C and 36°C TTM groups, respectively (P<0.01). During the rewarming phase, the norepinephrine and dopamine doses were 0.49±0.60 and 9.67±9.60 mcg·kg-1·min-1 in the 33°C TTM group and 0.14±0.46 and 3.13±7.19 mcg·kg-1·min-1 in the 36°C TTM group, respectively (P<0.01). The median cumulative vasopressor index was 8 (interquartile range, 3 to 8) and 4 (interquartile range, 0 to 8) in the 33°C and 36°C TTM groups, respectively (P=0.03).
Conclusion In this study, patients with OHCA due to acute myocardial infarction without cardiogenic shock had an elevated vasopressor requirement with 33°C TTM compared to 36°C TTM during the maintenance and rewarming phases.

참고문헌 (Reference)

1 Roberts BW, "Therapeutic hypothermia and vasopressor dependency after cardiac arrest" 84 : 331-336, 2013

2 Lewis ME, "The effects of hypothermia on human left ventricular contractile function during cardiac surgery" 39 : 102-108, 2002

3 Huynh N, "The effect of hypothermia “dose” on vasopressor requirements and outcome after cardiac arrest" 84 : 189-193, 2013

4 Zipes DP, "Sudden cardiac death" 98 : 2334-2351, 1998

5 Laurent I, "Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest" 40 : 2110-2116, 2002

6 Nolan JP, "Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Asso ciation Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke" 79 : 350-379, 2008

7 Reichenbach DD, "Pathology of the heart in sudden cardiac death" 39 : 865-872, 1977

8 Peberdy MA, "Part 9: post-cardiac arrest care. 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care" 122 (122): S768-S786, 2010

9 Marshall JC, "Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome" 23 : 1638-1652, 1995

10 Bro-Jeppesen J, "Hemodynamics and vasopressor support during targeted temperature management at 33°C Versus 36°C after out-of-hospital cardiac arrest: a post hoc study of the target temperature management trial" 43 : 318-327, 2015

11 Bergman R, "Haemodynamic consequences of mild therapeutic hypothermia after cardiac arrest" 27 : 383-387, 2010

12 Dekker LR, "Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients" 114 : 1140-1145, 2006

13 Dhainaut JF, "Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock" 35 : 1187-1195, 2009

14 Clutter WE, "Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man" 66 : 94-101, 1980

15 van den Broek MP, "Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies" 49 : 277-294, 2010

16 Tortorici MA, "Effects of hypothermia on drug disposition, metabolism, and response: a focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system" 35 : 2196-2204, 2007

17 Trzeciak S, "Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis" 34 : 2210-2217, 2008

18 Ambrose JA, "Angiographic correlates in type 1 and 2 MI by the universal definition" 5 : 463-464, 2012